Related references
Note: Only part of the references are listed.The Fabrazyme shortage-A call to action for metabolic physicians
Sandra Sirrs
MOLECULAR GENETICS AND METABOLISM (2011)
Expert opinion on temporary treatment recommendations for Fabry the disease during the shortage of enzyme replacement therapy (ERT)
Gabor E. Linthorst et al.
MOLECULAR GENETICS AND METABOLISM (2011)
Consequences of a global enzyme shortage of agalsidase beta in adult Dutch Fabry patients
Bouwien E. Smid et al.
ORPHANET JOURNAL OF RARE DISEASES (2011)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Natural course of Fabry disease: changing pattern of causes of death in FOS - Fabry Outcome Survey
A. Mehta et al.
JOURNAL OF MEDICAL GENETICS (2009)
Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data
A. Mehta et al.
LANCET (2009)
Fabry disease: recent advances in pathology, diagnosis, treatment and monitoring
Bjoern Hoffmann
ORPHANET JOURNAL OF RARE DISEASES (2009)
Lysosomal storage disease 3 - Fabry's disease
Yuri A. Zarate et al.
LANCET (2008)
Cardiac manifestations of Anderson-Fabry disease results from the international Fabry outcome survey
Ales Linhart et al.
EUROPEAN HEART JOURNAL (2007)
Clinical results of enzyme replacement therapy in Fabry disease: a comprehensive review of literature
O. Lidove et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2007)
Recommendations for chamber quantification: A report from the American Society of Echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology
RM Lang et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2005)
The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy
C Whybra et al.
CLINICAL GENETICS (2004)
Validation of the brief pain inventory for chronic nonmalignant pain
G Tan et al.
JOURNAL OF PAIN (2004)
Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey
A Mehta et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2004)
Enzyme therapy for Fabry disease: Neutralizing antibodies toward agalsidase alpha and beta
GE Linthorst et al.
KIDNEY INTERNATIONAL (2004)
Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males
KD MacDermot et al.
JOURNAL OF MEDICAL GENETICS (2001)
Share Paper
